Percutaneous transsplenic embolization of esophageal and gastrio - Fundal varices in 18 patients

World Journal of Gastroenterology

Volumn 7, Issue 6, 2001, Pages 880-883

  Gong, G Q ^a   Wang, X L ^a   Wang, J H ^a   Yan, Z P ^a   Cheng, J M ^a   Qian, S ^a   Chen, Y ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; DIURETIC AGENT;

ADULT; AGED; ANEMIA; ARTICLE; ARTIFICIAL EMBOLISM; ASCITES; BLEEDING; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL TRIAL; DEATH; DIURESIS; ERYTHROCYTE COUNT; ESOPHAGUS VARICES; FEMALE; FOLLOW UP; HUMAN; KIDNEY FAILURE; LIVER CELL CARCINOMA; LIVER FAILURE; MALE; MORTALITY; PORTAL PHLEBOGRAPHY; PORTAL VEIN THROMBOSIS; POSTOPERATIVE COMPLICATION; SAFETY; STOMACH FUNDUS; STOMACH VARICES; TREATMENT OUTCOME;

EID: 0035687103     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v7.i6.880     Document Type: Article

References (43)

1. Clinical research advances in primary liver cancer
2. Advances in clinical research of hepatocellular carcinoma in China
3. Effect of various drinking water on human micronucleus frequency in high-risk population of PHC
4. A retrospective review on interventional treatment of 10000 cases of liver cancer
5. New concept in etiology of liver cancer
6. Risk identification, assessment and control of primary hepatocellular cancer
7. Etiological studies of hepatocellular carcinoma
8. Hepatocellular carcinoma
9. Spontaneous gastroduodenal perforation in cancer patients receiving chemotherapy
10. Is choledocholithiasis a late complication of nonresectional therapies for hepatocellular carcinoma?
11. Treatment of spontaneous ruptured hepatocellular carcinoma
12. Review of 336 patients with hepatocellular carcinoma at Songklanagarind Hospital
13. Life-threatening haemorrhage from a sternal metastatic hepatocellular carcinoma
14. Clinical research of hepatocellular carcinoma in the 21st century
15. Stage II surgical resection of hepatocellular carcinoma after TAE: A report of 38 cases
16. Transduction of human hepatocellular carcinoma cells with human γ-interferon gene via retroviral vector
17. Arterial chemoembolization for hepatocellular carcinoma
18. Segmental transcatheter arterial embolization for primary hepatocellular carcinoma
19. Recent progress in anti-hepatoma monoclonal antibody and its application
20. Relationship between pathology and prognosis of liver cancer
21. Progresses in surgical treatment of primary hepatocellular carcinoma
22. Small hepatocellular carcinoma: Treatment with radio-frequency ablation versus ethanol injection
23. Immunological function and nutritional status in patients with hepatocellular carcinoma
24. Prevention and treatment of recurrences and metastases of hepatocellular carcinoma
25. Current situation of gene therapy studies in inhibition of liver cancer
26. Progress in research of liver surgery in China
27. Multimodality treatment in hepatocellular carcinoma patients with tumor thrombi in portal vein
28. Changes in hepatic functional reserve after transcatheter embolization of hepatocellular carcinoma
29. Tamoxifen in treatment of hepatocellular carcinoma: A randomised controlled trial
30. Des-γ-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma
31. A new method of antitumor therapy with a high dose of TNF perfusion for unresectable liver tumors
32. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: Evaluation of damage to nontumorous liver tissue-long-term prospective study
33. Retrograde transvenous obliteration of gastric varices
34. Balloon-occluded retrograde transvenous obliteration of high risk gastric fundal varices
35. Vascular and interventional case of the day. Peristomal varices
36. Interventional radiology and endoscopic therapy for recurrent esophageal varices
37. Hepatocellular carcinoma with portal vein tumor thrombus
38. Magnetic resonance angiography for monitoring prophylactic endoscopic treatment of high risk esophageal varices
39. Gastrointestinal bleeding in cirrhotic patients with hepatocellular carcinoma undergoing intrahepatic artery chemotherapy
40. Clinical efficacy of portal vein stent placement in patients with hepatocellular carcinoma invading the main portal vein
41. Injection sclerotherapy for variceal bleeding in patients with irresectable hepatocellular carcinoma
42. Animal experiments and clinical application of CT during percutaneous splenoportography
43. Percutaneous transsplenic catheterization of the portal venous system